Kava root is generally safe when used short-term in moderate amounts, but it carries real risks, particularly to the liver. Clinical trials lasting up to eight weeks have found that side effects from kava are comparable to placebo, and a systematic review of seven randomized trials showed no significant difference in adverse events between kava and sugar pills. But rare cases of serious liver injury, including liver failure requiring transplant, have been documented worldwide, making kava one of those supplements where the details matter enormously.
How Kava Works in the Body
Kava’s active compounds, called kavalactones, produce calming, muscle-relaxing, and mildly pain-relieving effects. They work primarily by amplifying the activity of GABA receptors in the brain, the same system that benzodiazepines like Valium target. However, kavalactones don’t bind to the same spot on the receptor that benzodiazepines do. Instead, they enhance the receptor’s response to GABA through a different mechanism, one that shares more in common with how general anesthetics work at the molecular level.
Kavalactones also appear to interact with sodium and calcium channels, opioid receptors, dopamine receptors, and other systems. Scientists haven’t fully mapped out which of these pathways contribute most to kava’s effects, but the GABA connection is the strongest explanation for the relaxation and anxiety relief that users experience.
What the Clinical Evidence Shows for Anxiety
A systematic review of seven randomized clinical trials found that kava was more effective than placebo in three of those trials. Pooling data from five trials with 330 total participants, people taking kava were about 50% more likely to be classified as treatment responders compared to those on placebo. That’s a meaningful effect, though not overwhelming, and it places kava somewhere in the range of a mild to moderate anxiolytic.
Importantly, lab values tracking liver function in these trial participants were no different from baseline in most studies. The trials were relatively short, though, typically eight weeks or less. Longer-term safety data from controlled studies is limited, which is where uncertainty starts to creep in.
The Liver Risk Is Rare but Serious
Between 1990 and 2002, a detailed evaluation identified 36 cases of liver injury attributed to kava in published and unpublished reports, mostly from Germany. Of those, three were rated as “certain” and 21 as “probable” for causation. Nine patients developed acute liver failure, eight needed a liver transplant, and three died. The time from starting kava to developing symptoms ranged from two weeks to two years, with a median of about four and a half months.
One well-documented case involved a person taking 180 mg of kavalactones daily who developed severe hepatitis after 12 weeks. Within two more weeks, their liver function had deteriorated so badly that a transplant was required. The patient died from surgical complications. Other causes of liver injury were ruled out.
To put this in perspective, kava-related liver failure is rare in absolute terms. Among roughly 50,000 liver transplants reported in the U.S. during that same period, only one was specifically attributed to kava. But the severity of the potential outcome is what prompted regulatory action across multiple countries. The FDA determined in 2020 that kava is not Generally Recognized as Safe (GRAS) for use in food products, and the agency has issued warning letters to companies marketing kava-containing items.
The mechanism behind kava’s liver toxicity remains unclear. Some cases show features of an immune-mediated allergic reaction, including rash, fever, and recurrence when someone tries kava again. This suggests certain individuals may be genetically susceptible rather than liver damage being a predictable dose-dependent effect.
Noble Kava vs. Tudei Kava
Not all kava is the same plant material. Noble kava varieties contain higher levels of kavain, the kavalactone most associated with pleasant, short-lasting relaxation. These are the cultivars traditionally consumed in Pacific Island cultures and generally considered the safest option.
Tudei kava (sometimes called “two-day kava”) has a different chemical profile, with higher concentrations of compounds that produce more intense, longer-lasting, and often unpleasant effects. Nausea, headaches, and a lingering heavy feeling can persist for two days or more. Researchers and Pacific Island kava cultures alike consider tudei varieties lower quality and less safe. If you’re buying kava, look for products that specify noble cultivars.
Extraction Method Matters Less Than You Might Think
A common claim is that traditional water-based kava preparation is safe while modern alcohol or acetone extracts are dangerous. The evidence doesn’t fully support this distinction. While early liver injury reports came primarily from European patients using ethanol and acetone extracts, a later analysis established causality for liver damage in five patients who consumed traditional water-based kava preparations in New Caledonia, Australia, the United States, and Germany.
The clinical picture of liver injury looked similar regardless of how the kava was extracted. This suggests the toxicity is linked to the kava plant itself, possibly to the cultivar used or which parts of the plant were included (stems and leaves versus root only), rather than to the solvent used in extraction.
Drug Interactions
Kava inhibits several of the liver enzymes responsible for breaking down medications. In laboratory studies, it has shown potent inhibition of at least six major drug-metabolizing enzymes. This means kava can cause other drugs to build up to higher-than-expected levels in your blood, potentially reaching toxic concentrations.
This is particularly concerning with psychiatric medications. In documented cases, kava use alongside an antipsychotic led to cardiotoxic effects because the drug wasn’t being cleared from the body at a normal rate. In another case, combining kava with a Parkinson’s medication triggered acute psychosis from excessive dopamine stimulation. Any medication that relies on liver processing for clearance, which includes most prescription drugs, could theoretically be affected.
Alcohol compounds this problem. Drinking alcohol while using kava places additional strain on the liver and likely increases the risk of liver injury.
Skin Changes From Heavy Use
Heavy, long-term kava consumption causes a distinctive skin condition called kava dermopathy. The skin becomes dry, scaly, and flaky in a pattern resembling a condition called ichthyosis. The cause isn’t fully understood but may involve disruption of cholesterol metabolism in the skin. The condition is reversible once kava use stops, and it primarily affects people who drink large quantities regularly over extended periods.
Who Should Avoid Kava
People with existing liver disease or a history of liver problems face a higher baseline risk and should not use kava. Kava also carries special risks during pregnancy and breastfeeding because certain compounds in the plant can cross into fetal circulation and breast milk. Anyone taking prescription medications, especially psychiatric drugs, sedatives, or medications metabolized by the liver, should be aware of the significant interaction potential. Combining kava with other sedating substances, including alcohol, benzodiazepines, or sleep medications, amplifies sedation and liver stress.
Practical Guidelines for Safer Use
If you choose to use kava, several factors can reduce your risk. Stick to products made from noble kava varieties and from the root only, not stems, leaves, or bark. Keep use to eight weeks or less, which is the window where clinical trial data supports a safety profile similar to placebo. Use moderate doses rather than escalating for stronger effects.
Pay attention to early warning signs of liver trouble: unusual fatigue, loss of appetite, nausea, dark urine, or yellowing of the skin or eyes. These symptoms typically appear between two weeks and several months after starting kava. If any of these develop, stop using kava immediately.